Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Westphal

Showing results (241-250 of 309) with videos related to

Pageof 31
Sort By:
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
Science Translational Medicine|August 1, 2014
Hematogenous dissemination of glioblastoma multiformeCarolin Müller, Johannes Holtschmidt, Martina Auer, et al.
Oncotarget|May 17, 2014
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patientsHarriet Wikman, Laura Westphal, Felicitas Schmid, et al.
Journal of Neuro-Oncology|September 4, 2003
Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant gliomaFriedrich Weber, Anthony Asher, Richard Bucholz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma NetworkMichael Weller, Jörg Felsberg, Christian Hartmann, et al.
Neurology|September 27, 2013
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutationWolfgang Wick, Christoph Meisner, Bettina Hentschel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating LymphocytesMalte Mohme, Simon Schliffke, Cecile L Maire, et al.
Breast Cancer Research : BCR|September 5, 2019
Clonality of circulating tumor cells in breast cancer brain metastasis patientsCarlotta Riebensahm, Simon A Joosse, Malte Mohme, et al.
Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology|July 22, 2022
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patientsRichard Drexler, Ulrich Schüller, Alicia Eckhardt, et al.
Pageof 31

Showing results (241-250 of 309) with videos related to

Sort By:
Pageof 31
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
Science Translational Medicine|August 1, 2014
Hematogenous dissemination of glioblastoma multiformeCarolin Müller, Johannes Holtschmidt, Martina Auer, et al.
Oncotarget|May 17, 2014
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patientsHarriet Wikman, Laura Westphal, Felicitas Schmid, et al.
Journal of Neuro-Oncology|September 4, 2003
Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant gliomaFriedrich Weber, Anthony Asher, Richard Bucholz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma NetworkMichael Weller, Jörg Felsberg, Christian Hartmann, et al.
Neurology|September 27, 2013
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutationWolfgang Wick, Christoph Meisner, Bettina Hentschel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating LymphocytesMalte Mohme, Simon Schliffke, Cecile L Maire, et al.
Breast Cancer Research : BCR|September 5, 2019
Clonality of circulating tumor cells in breast cancer brain metastasis patientsCarlotta Riebensahm, Simon A Joosse, Malte Mohme, et al.
Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology|July 22, 2022
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patientsRichard Drexler, Ulrich Schüller, Alicia Eckhardt, et al.
Pageof 31